NCT06488157

Brief Summary

The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

July 10, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2025

Completed
3 months until next milestone

Results Posted

Study results publicly available

August 27, 2025

Completed
Last Updated

August 27, 2025

Status Verified

August 1, 2025

Enrollment Period

11 months

First QC Date

June 28, 2024

Results QC Date

July 29, 2025

Last Update Submit

August 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility, as Measured by the Percentage of Caregivers Who Enroll in the Study

    Feasibility was measured by the percentage of caregivers who enrolled in the study out of all eligible participants.

    Recruitment (7 months)

  • Feasibility, as Measured by the Percentage of Tele-visits Conducted

    Feasibility was measured by dividing the number of tele-visits conducted by the number of tele-visits that could have been conducted, then multiplying by 100. This measure shows the adherence of the intervention arm to the tele-visits. The percentage is calculated for the group rather than the individual patient.

    At the end of the intervention or at 12 weeks, whichever is earlier

Secondary Outcomes (5)

  • Change in Behavioral and Psychosocial Symptoms of Dementia (BPSD) in the Patient, as Measured by the Neuropsychiatric Inventory Questionnaire

    Baseline, 2, 4, 6, 8, 10, 12 weeks

  • Mean Caregiver Depression Score, as Measured by Patient Health Questionnaire-8

    Baseline, 2, 4, 6, 8, 10, 12 week

  • Mean Caregiver Anxiety Score, as Measured by General Anxiety Disorder-7

    Baseline, 2, 4, 6, 8, 10, 12 weeks

  • Mean Caregiver Burden Score, as Measured by the Zarit Burden Interview - Short Version

    Baseline, 2, 4, 6, 8, 10, 12 weeks

  • Mean Caregiver Perception of Patient's Pain Score, as Measured by the Doloplus 2 Scale Behavioral Assessment

    Baseline, 2, 4, 6, 8, 10, 12 weeks

Study Arms (1)

Intervention (I-HoME)

EXPERIMENTAL

Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs.

Other: I-HoME

Interventions

I-HoMEOTHER

Video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs

Intervention (I-HoME)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old and \< 100 years
  • English speaking
  • Providing care to an ADRD patient who is age ≥ 65 years old and \< 105 years who is a stage 7a-f on the Functional Assessment Staging Tool (FAST) scale

You may not qualify if:

  • Non-English speaking
  • \<18 years old or \>100 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medicine

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Caregiver Burden

Condition Hierarchy (Ancestors)

Stress, PsychologicalBehavioral SymptomsBehavior

Results Point of Contact

Title
Dr. Veerawat Phongtankuel
Organization
Weill Cornell Medicine

Study Officials

  • Veerawat Phongtankuel, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2024

First Posted

July 5, 2024

Study Start

July 10, 2024

Primary Completion

May 23, 2025

Study Completion

May 23, 2025

Last Updated

August 27, 2025

Results First Posted

August 27, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations